Searched for
EFFICACY RATES
Psychologists say one belief separates workers who bounce back after layoffs from those who struggleLosing a job can take a toll on both finances and mental health, but psychologists say one belief can make recovery easier: confidence in y...- Psychology says people who honk in heavy traffic may not be impatient, they could be reacting to stress, loss of control and mental overloadWhy do some people repeatedly honk in heavy traffic? Psychology suggests the behavior may be linked to frustration, stress, perceived loss ...
- Psychology says people who always take a shower before bed may not just be cleaning up, they could be washing away the mental weight of the dayWhy do some people refuse to sleep without taking a shower first? Psychology suggests the habit may be linked to emotional regulation, stre...
- Psychologists asked 1,442 young people about the moments that shaped them, and 83% of the memories were positive, not painfulContrary to popular belief, young people's most formative memories are overwhelmingly positive, a University of Zurich study reveals. Every...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- FDA approval puts Wockhardt’s Zaynich in $9 billion antibiotics marketWockhardt's new antibiotic, Zaynich, has received US FDA approval. This drug uses a novel mechanism to fight drug-resistant bacteria. It ta...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- The 2013 ghost returns: Will higher gold duties actually restrict imports or just fuel the grey market?India’s shock hike in gold and silver import duty to 15% has revived memories of the 2013 crisis. While the move aims to curb dollar outflo...
- Govt awarded 172 oil & gas blocks in 10 years, but negligible output brings policy and execution into focusIndia's ambitious oil and gas policy has failed to boost domestic production. Despite billions invested and extensive exploration, only one...
- India’s rupee defence faces tough test as capital flows stallIndia’s rupee faces sustained pressure as weak capital inflows and elevated oil prices strain the balance of payments. Despite RBI interven...
- Pakistan approves emergency use of third Chinese COVID-19 vaccine despite low efficacy rateThe Drug Regulatory Authority of Pakistan (DRAP) on Thursday granted Emergency Use Authorisation (EUA) to CoronaVac, developed by Chinese c...
- Pakistan approves emergency use of third Chinese COVID vaccine, despite its low efficacy rateCiting officials, Geo News reported that the Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) to ...
- Need to change Covaxin composition not felt yet due to vaccine's good efficacy against mutant variants: GovernmentProviding details of the efficacy rate of Covaxin and Covishield vaccines against each of the mutations, he said there was no significant d...
- Growing uncertainty over efficacy of China made SinovacThe Sinovac allegedly has shown four different efficacy rates during clinical trials ranging from over 91 to 50 per cent. The global scient...
- Explainer: What's behind varying efficacy data for Sinovac's coronavirus vaccine?Researchers in Brazil said it was 50.4% effective at preventing symptomatic infections, barely enough for regulatory approval and below the...
- The curious case of AstraZeneca-Oxford vaccineThe company announced that in a small subgroup of the trial participants the vaccine showed better efficacy when administered a half dose f...
- 3 Covid vaccines’ efficacy higher than flu shotsAnthony Fauci, top infectious disease expert in the US, had said the over 90% efficacy of Pfizer vaccine candidate ‘is just extraordinary’ ...
- Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virusSpeaking in a briefing, Andrew Pollard, director of the Oxford Vaccine Group, said it is hard to explain the different efficacy rates betwe...
Load More
